Forest Pharmaceuticals, Inc. manufactures finished products – tablets,
capsules, and solutions – in state-of-the-art facilities in Ireland and Ohio. Combined with the company’s leading
edge packaging facilities in New York, Ohio, and Missouri, our FDA-licensed U.S. manufacturing operations are
capable of producing more than 16 billion solid-form doses and 2 million liters of liquid annually.
Our IMB- and MCA-licensed solid dosage manufacturing and packaging facilities in Europe have the capacity to
produce more than 4 billion doses each year.
These recently expanded facilities are designed to meet the production and packaging needs of
Forest’s current portfolio as well as the future growth of our product line. To ensure full, effective, and compliant
use of these facilities, our supply chain team has honed an integrated approach to process design, planning, materials
procurement, and quality assurance/quality control. From initial planning to manufacturing, packaging, labeling, and
distribution, our team ensures that our drugs are produced safely, efficiently, consistently, and in the quantities needed
to provide an uninterrupted supply.
Leveraging the latest technologies, efficient practices, and strict quality control enables Forest to
convert raw materials into products that are used to treat patients across the country.